Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in postate cancer

Disease Markers

Volumn 21, Issue 1, 2005, Pages 37-41

  Li, He Cheng ^a,c   Cai, Qiu Yin ^b   Shinohara, Eric T ^b   Cai, Hui ^b   Cao, Carolyn ^b   Wang, Zuo Fei ^b   Teng, Ming ^b   Zheng, Wei ^b   Lu, Bo ^b  

^a FUDAN UNIVERSITY   (China)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endostatin; Polymorphism; Prostate cancer

Indexed keywords

AMINO ACID; ENDOSTATIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FISHER EXACT TEST; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; SURVIVAL RATE; TISSUE SECTION;

MARTES PENNANTI;

EID: 15244361180     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/650109     Document Type: Article

References (18)

1. D. Parkin, Royal College of Nursing, Momentum, Nurs Stand 452(1986), 1-4.
2. D.M. Parkin, E. Laara and C.S. Muir, Estimates of the worldwide frequency of sixteen major cancers in 1980, Int J Cancer 41 (1988), 184-197.
3. D.M. Parkin, P. Pisani and J. Ferlay, Estimates of the worldwide incidence of 25 major cancers in 1990, Int J Cancer 80 (1999), 827-841.
4. M. Quinn and P. Babb, Patterns and trends in prostate cancer incidence, survival, prevalence and mortality, Part I: international comparisons, BJU Int 90 (2002), 162-173.
5. J.A. Siegal, E. Yu and M.K. Brawer, Topography of neovascularity in human prostate carcinoma. Cancer 75 (1995), 2545-2551.
6. D. Hanahan and J. Folkman, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell 86 (1996), 353-364.
7. T. Sasaki, N. Fukai, K. Mann, W. Gohring, B.R. Olsen and R. Timpl, Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin, Embo J 17 (1998), 4249-4256.
8. Y. Yokoyama, J.E. Green, V.P. Sukhatme and S. Ramakrishnan, Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model, Cancer Res 60 (2000), 4362-4365.
9. S.S. Yoon, H. Eto, C.M. Lin, H. Nakamura, T.M. Pawlik, S.U. Song and K.K. Tanabe, Mouse endostatin inhibits the formation of lung and liver metastases, Cancer Res 59 (1999), 6251-6256.
10. G. Perletti, P. Concari, R. Giardini, E. Marras, F. Piccinini, T. Folkman and L. Chen, Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors, Cancer Res 60 (2000), 1793-1796.
11. H. Hasle, I.H. Clemmensen and M. Mikkelsen, Risks of leukaemia and solid tumours in individuals with Down's syndrome, Lancet 355 (2000), 165-169.
12. T. Visakorpi, Molecular genetics of prostate cancer, Ann Chir Gynaecol 88 (1999), 11-16.
13. P. Iughetti, O. Suzuki, P.H. Godoi, V.A. Alves, A.L. Sertie, T. Zorick, F. Scares, A. Camargo, E.S. Moreira, C. di Loreto, C.A. Moreira-Filho, A. Simpson, G. Oliva and M.R. Passos-Bueno, A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma, Cancer Res 61 (2001), 7375-7378.
14. Prostate, in: American Joint Commitee on Cancer: AJCC Cancer Staging Manual, 6 eds, Springer, New York, 2002, pp. 309-316.
15. O. Musso, M. Rehn, N. Theret, B. Turlin, P. Bioulac-Sage, D. Lotrian, J.P. Campion, T. Pihlajaniemi and B. Clement, Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas, Cancer Res 61 (2001), 45-49.
16. A. Loktionov, Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 208 (2004), 1-33.
17. M.M. Ortega, H. Nascimento, F.F. Costa, M.T. Teori and C.S. Lima, A polymorphism in the angiogenesis inhibitor, endostatin, in multiple myeloma, Leuk Res 27 (2003), 93-94.
18. T.C. Liu, C.T. Peng, S.F. Lin, C.S. Chang, T.P. Chen and J.G. Chang, Assocation of endostatin D104N with leukemia, Kaohsiung J Med Sci 19 (2003), 1-5.